VERU Veru Inc.

XNAS 2.21 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

VERU $2.21 —
Key stats
$2.21
Pre-market $2.21 +0.00%
52-Week Range
$2.05 – $7.33
YTD
-2.64%
IV Rank (30D)
53.26
Straddle Price
$0.93
Market Cap
$0.0B
Open
$2.25
Day Range
$2.18 – $2.26
Volume
86,578
Prev Close
$2.24
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.37
Cost of Equity (CAPM)6.82% (VRP-adj)
WACC6.97%
Volatility Risk Premium+86.9pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-48.0%
Book / Price86.6% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$2.49 (Market Anchor value)
SMA 20 / Bollinger Mid$2.39
Bollinger Width / SMA20963.3% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABT, NVS, PFE (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$6.72
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 39.5× · 3 peers
Peer EV/EBITDA n/a 0% median 19.2× · 3 peers
Peer P/B $6.72 100% median 3.5× · 3 peers
Peer P/S n/a 0% median 3.9× · 3 peers
Market Anchor (SMA50) $2.49 0% stability 0% (BB-width)
Options Expected (B-L 30d) $2.14 0% 5 strikes · skew +0.13
As of 2026-10-27 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
20
List Date
1990-06-01
CIK
0000863894
Next Earnings
2026-12-16 (After-Close)
EPS Forecast
($0.34) (3 est.)
Headquarters
Miami, FL
Homepage
https://www.verupharma.com

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflamma…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan9.57%-16.26%12.06%-32.41%-14.74%11.45%-5.05%
Feb43.36%1.08%-32.97%23.49%-12.80%0.39%3.76%
Mar-25.23%-13.13%-69.15%9.39%-2.23%-15.65%-19.33%
Apr-21.07%141.65%11.40%77.63%-15.33%-0.88%32.23%
May-1.34%26.00%-26.12%-32.21%-3.11%4.87%-5.32%
Jun-9.12%-7.30%21.94%-16.70%0.81%31.51%3.52%
Jul-15.81%8.04%5.00%6.54%-17.85%-28.78%-7.14%
Aug26.35%28.90%-13.33%-7.95%-34.14%23.89%3.95%
Sep-4.05%-24.71%-30.87%-15.49%15.85%-1.12%-10.06%
Oct-3.43%-0.33%23.85%-1.41%-24.16%-12.99%*-3.08%
Nov-11.14%-54.23%9.83%-7.31%-4.62%---13.49%
Dec-14.76%-3.65%-28.71%-6.38%-11.93%---13.09%
Total-37.95%-4.35%-85.81%-35.06%-76.00%-2.06%-40.21%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $2.39
SMA 50: $2.49
SMA 200: $2.50
Current: $2.21
EMA 12: $2.31
EMA 26: $2.38
MACD: -0.0679 | Signal: -0.0119
BEARISH
ADX (14): 16.74
RANGE
+DI: 18.18
−DI: 18.91

Momentum Oscillators

RSI (14): 40.40
NEUTRAL
Stoch %K: 23.90
Stoch %D: 27.76
Williams %R: -76.74

Volume & Volatility

BB Upper: $2.67
BB Lower: $2.12
NEUTRAL
OBV: 77,692,486
Vol SMA 20: 219,756
Vol ROC: 1.24%
ATR: $0.13
True Range: $0.08
HV 20: 72.5%
HV 30: 61.1%
HV 60: 64.5%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 8/10)

Key drivers:

  • Bullish MACD signal
  • Weak trend regime, indicating potential reversal
  • Positive news sentiment from recent headlines

Primary risks:

  • High volatility, increasing the risk of significant price movements
  • Limited earnings data available to assess the company's financial performance

Investment thesis: VERU is poised for a potential rebound due to its weak trend regime and positive news sentiment. However, the high volatility and limited earnings data make it essential to closely monitor the stock's price action and news headlines.

Recent news sentiment impact: The recent news headlines are overwhelmingly positive, which could continue to support the stock's price in the short term.

Technical Analysis

Trend Direction: Weak trend regime (ADX/DMI), indicating potential reversal

Support/Resistance Levels:

  • SMA 20: $2.68
  • SMA 50: $2.58
  • SMA 200: $2.49
  • Upper Bollinger Band: $2.83

Momentum Signals:

  • RSI (14): 47.76 (neutral)
  • MACD signal: 0.03 / Signal: -0.01 / Histogram: 0.04 (bullish)
  • Williams %R: -77.10 (oversold)

Volume Analysis: Volume SMA 20: 231018.25, indicating moderate volume interest.

News & Sentiment Analysis

Recent Headlines Summary: The recent headlines focus on VERU's sale of its condom business and its biopharma pipeline, which could positively impact the company's financial performance.

Sentiment Assessment: Positive sentiment dominates the recent headlines (4/5).

Catalyst Identification: The upcoming Leerink Therapeutics Forum: I&I and Metabolism presentation could provide additional insights into VERU's pipeline development.

Market Narrative: The news aligns with the technical signals, suggesting a potential rebound in the short term.

Risk & Volatility Assessment

Beta Interpretation: Beta 2.27 (vs SPY), indicating high risk relative to the market.

Volatility Regime: High volatility regime, increasing the risk of significant price movements.

Options Market Signals: IV Rank: 13.2% (Low - shows if volatility is historically high/low), indicating low historical volatility.

Downside Protection: Support levels: SMA 20 ($2.68) and Lower Bollinger Band ($2.54).

Market Context & Positioning

Sector Performance: VERU's sector performance is neutral, with the sexual wellness market expected to grow at a CAGR of 4.7% by 2031.

Institutional Activity: Institutional interest is moderate, as indicated by the volume SMA 20 and OBV data.

Correlation Analysis: The stock moves relatively strongly (R-squared: 0.26) compared to the market.

Relative Valuation: VERU's relative valuation is neutral within its trading range.

Key Levels & Action Items

Critical Price Levels:

  • Support: SMA 20 ($2.68), Lower Bollinger Band ($2.54)
  • Resistance: Upper Bollinger Band ($2.83)

Breakout/Breakdown Levels: None identified based on the provided data.

Time-Sensitive Catalysts: The upcoming Leerink Therapeutics Forum: I&I and Metabolism presentation (June 27, 2024) could provide additional insights into VERU's pipeline development.

Risk Management: Monitor the stock's price action closely, considering stop-loss levels at SMA 20 ($2.68) and Lower Bollinger Band ($2.54).

Note: This analysis is based on the provided data and should not be taken as investment advice.

Generated
Earnings History
17 of 21 under expected move
Avg Expected Move
21.35%
Avg Actual Move
6.79%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-02-10 After-Close 29.69% 2.08% 0.07x Within
2021-05-12 After-Close 4.17% 0.14% 0.03x Within
2021-08-12 After-Close 9.21% 1.75% 0.19x Within
2021-12-02 After-Close 21.33% 12.81% 0.60x Within
2022-02-09 After-Close 2.67% 3.00% 1.12x Exceeded
2022-05-12 After-Close 9.00% 43.96% 4.88x Exceeded
2022-08-11 After-Close 9.98% 19.18% 1.92x Exceeded
2022-12-05 After-Close 15.34% 2.75% 0.18x Within
2023-02-09 After-Close 6.20% 4.53% 0.73x Within
2023-05-11 After-Close 19.69% 7.32% 0.37x Within
2023-08-10 After-Close 3.76% 4.59% 1.22x Exceeded
2024-02-08 After-Close 22.73% 7.61% 0.33x Within
2024-05-08 After-Close 18.88% 4.20% 0.22x Within
2024-08-08 After-Close 54.17% 1.69% 0.03x Within
2025-02-13 After-Close 8.36% 3.01% 0.36x Within
2025-05-08 Pre-Market 19.92% 4.15% 0.21x Within
2025-08-12 After-Close 86.75% 7.57% 0.09x Within
2025-12-17 After-Close 19.06% 1.35% 0.07x Within
2026-02-11 After-Close 29.35% 2.61% 0.09x Within
2026-05-13 After-Close 45.35% 7.52% 0.17x Within
2026-08-10 After-Close 12.64% 0.72% 0.06x Within

Earnings calendar: this week’s reports with expected vs actual moves →

VERU Options Activity & IV Rank

VERU IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 145.3%
7-DTE IV: 195.2%
Expected Move: $0.93
7-DTE Move: $0.53
Days to Exp: 32 (2026-11-27)

Options Flow

Call Volume: 0
Put Volume: 0
P/C Volume: —
Call OI: 0
Put OI: 0
P/C OI: —
Total OI: 0

ATM Options Pricing

ATM Call: $0.50
ATM Put: $0.42
Call %: 22.6%
Put %: 19.2%

Chain Summary

Chain Volume: 1,115
Chain OI: 7,114
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 27th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
27%
vs own history
GEX tilt
+0.37
OI-weighted, today
Vanna tilt
-0.16
δ-sensitivity to IV
Charm tilt
-0.47
δ-decay vs time
Charm tilt -0.47: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 5 ATM contracts, 0k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 148.0% / Wing —
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 93.2% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)50.6MediumOct 26
IV Rank (30 DTE)53.3MediumOct 26
Straddle Price (30 DTE)$0.93Oct 26
Beta Analysis

Risk Metrics

Beta: 2.1412
Alpha: -36.02%
Correlation: 0.2488
R-Squared: 6.2%
Stock Volatility: 109.7%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own VERU
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$515K
0.00%
#2600 of 3138+137.5%13F
Citadel Hedge fund
Ken Griffin
$194K
0.00%
#5511 of 6285+39.3%13F
Rockefeller Capital Management Family office
Rockefeller family
$1K
0.00%
#4576 of 47290.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

VERU Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 18,166,395 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

62 filers3,859,218 shares$11.66M value21.24% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 698,439 $2.19M 18.75% 3.84% 2026-06-30
2 Vanguard Group Inc Custodian 634,038 $1.36M 11.63% 3.49% 2025-12-31
3 Sheets Smith Investment Management 322,084 $1.22M 10.49% 1.77% 2025-09-30
4 Alyeska Investment Group, L.P. 238,556 $746.68K 6.40% 1.31% 2026-06-30
5 OPPENHEIMER & CO INC 210,843 $659.94K 5.66% 1.16% 2026-06-30
6 BlackRock, Inc. Custodian 167,084 $522.97K 4.48% 0.92% 2026-06-30
7 RENAISSANCE TECHNOLOGIES LLC 164,450 $514.73K 4.41% 0.91% 2026-06-30
8 GSA CAPITAL PARTNERS LLP 157,336 $492.00K 4.22% 0.87% 2026-06-30
9 Geode Capital Management, LLC Custodian 155,076 $485.55K 4.16% 0.85% 2026-06-30
10 Summit Financial, LLC 141,865 $444.04K 3.81% 0.78% 2026-06-30
11 Jane Street Group, LLC Custodian 127,853 $400.18K 3.43% 0.70% 2026-06-30
12 Raymond James Financial, Inc. Custodian 84,969 $265.95K 2.28% 0.47% 2026-06-30
13 Vanguard Fiduciary Trust Co 81,230 $254.25K 2.18% 0.45% 2026-06-30
14 CHOREO, LLC 74,813 $234.16K 2.01% 0.41% 2026-06-30
15 NewEdge Advisors, LLC 70,439 $220.47K 1.89% 0.39% 2026-06-30
16 Citadel Advisors LLC Custodian 61,977 $193.99K 1.66% 0.34% 2026-06-30
17 BLAIR WILLIAM & CO/IL 58,000 $181.54K 1.56% 0.32% 2026-06-30
18 State Street Corp 55,004 $172.16K 1.48% 0.30% 2026-06-30
19 Diametric Capital, LP 50,192 $157.10K 1.35% 0.28% 2026-06-30
20 ALGERT GLOBAL LLC 42,144 $131.91K 1.13% 0.23% 2026-06-30
21 ADAR1 Capital Management, LLC 35,000 $109.55K 0.94% 0.19% 2026-06-30
22 Northern Trust Corp Custodian 29,855 $93.45K 0.80% 0.16% 2026-06-30
23 Scientech Research LLC 28,391 $88.86K 0.76% 0.16% 2026-06-30
24 T. Rowe Price Associates, Inc. 24,765 $78.00K 0.67% 0.14% 2026-06-30
25 Marshall Wace, LLP Custodian 20,300 $63.54K 0.54% 0.11% 2026-06-30
7 filers$1.68M notional
# Filer Notional Value % of Total Period
1 GROUP ONE TRADING LLC Custodian $642.90K 38.29% 2026-06-30
2 Susquehanna International Group, LLP Custodian $295.47K 17.60% 2026-06-30
3 Simplex Trading, LLC Custodian $239.44K 14.26% 2026-06-30
4 Jane Street Group, LLC Custodian $205.33K 12.23% 2026-06-30
5 Citadel Advisors LLC Custodian $186.55K 11.11% 2026-06-30
6 Verition Fund Management LLC $62.60K 3.73% 2026-06-30
7 Caption Management, LLC $46.95K 2.80% 2026-06-30
5 filers$756.52K notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $452.29K 59.78% 2026-06-30
2 Susquehanna International Group, LLP Custodian $233.50K 30.86% 2026-06-30
3 Jane Street Group, LLC Custodian $44.76K 5.92% 2026-06-30
4 GROUP ONE TRADING LLC Custodian $17.84K 2.36% 2026-06-30
5 Simplex Trading, LLC Custodian $8.14K 1.08% 2026-06-30

VERU Insider Trading (Form 4)

Latest: 2026-08-17
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-17 K Gary Barnette Chief Scientific Officer Buy (P) +1,800 $2.69 $4.8K EDGAR
2026-05-06 Loren Mark Katzovitz Director Grant (A) +102,000 opt — EDGAR
2026-05-06 Lucy Lu Director Grant (A) +104,000 opt — EDGAR
2026-05-06 Grace Hyun Director Grant (A) +97,000 opt — EDGAR
2026-05-06 Harry Fisch Chief Corporate Officer Grant (A) +160,000 opt — EDGAR
2026-05-06 Michele Greco Chief Admin Officer and CFO Grant (A) +164,000 opt — EDGAR
2026-05-06 Mitchell Shuster Steiner President and CEO Grant (A) +604,000 opt — EDGAR
2026-05-06 K Gary Barnette Chief Scientific Officer Grant (A) +160,000 opt — EDGAR
2026-05-06 Michael L Rankowitz Director Grant (A) +100,000 opt — EDGAR
2025-12-09 Mitchell Shuster Steiner President and CEO Grant (A) +100,000 opt — EDGAR
2025-12-09 Michael L Rankowitz Director Grant (A) +3,000 opt — EDGAR
2025-12-09 Harry Fisch Chief Corporate Officer Grant (A) +27,000 opt — EDGAR
2025-12-09 Michele Greco Chief Admin Officer and CFO Grant (A) +27,000 opt — EDGAR
2025-12-09 Lucy Lu Director Grant (A) +4,000 opt — EDGAR
2025-12-09 K Gary Barnette Chief Scientific Officer Grant (A) +27,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

VERU Insider Holdings

7 insiders · @ $2.21
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Harry Fisch Chief Corporate Officer 801,384 $1.77M -$361.3K 44 2026-05-06
2 Mitchell Shuster Steiner President and CEO 715,039 $1.58M -$3.58M 44 2026-05-06
3 Michael L Rankowitz Director 25,000 $55.2K $84.4K 16 2026-05-06
4 Michele Greco Chief Admin Officer and CFO 9,618 $21.3K $50.0K 15 2026-05-06
5 K Gary Barnette Chief Scientific Officer 2,300 $5.1K -$906.8K 16 2026-08-17
6 Grace Hyun Director 1,479 $3.3K $49.3K 15 2026-05-06
7 Lucy Lu Director 980 $2.2K $32.5K 13 2026-05-06
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

VERU Board & Officers

As of SEC filings through Aug 17, 2026

Directors 6

Officers 4

Changes in the last 10 years (31)
Aug 1, 2024Loren Mark Katzovitz became a director
May 9, 2024Mitchell Shuster Steiner no longer listed as a 10% owner in SEC filings
May 11, 2023Harry Fisch no longer listed as a 10% owner in SEC filings
Apr 25, 2022Harry Fisch first listed as Chief Corporate Officer in an SEC filing
Nov 5, 2021Michele Greco listed as Chief Admin Officer and CFO (previously CAO and CFO) in SEC filings
Aug 11, 2020Grace Hyun became a director
May 21, 2019Michele Greco listed as CAO and CFO (previously Chief Admin Officer & CFO) in SEC filings
Jan 2, 2019Charles T Todd Jr became CEO of FHC Division
Sep 4, 2018K Gary Barnette became Chief Scientific Officer
May 4, 2018Michele Greco listed as Chief Admin Officer & CFO (previously Executive VP of Finance) in SEC filings
Mar 20, 2018Robert Getzenberg became Chief Scientific Officer
Mar 20, 2018Michael L Rankowitz became a director
Jan 16, 2018Michele Greco first listed as Executive VP of Finance in an SEC filing
Mar 16, 2017Jesus Socorro became a director
Feb 28, 2017Daniel Haines listed as Chief Financial Officer (previously CFO and COO) in SEC filings
Jan 1, 2017Brian J. Groch became Chief Commercial Officer
Nov 2, 2016O B Parrish no longer listed as Chief Executive Officer in SEC filings
Nov 2, 2016Michele Greco reported in an SEC filing no longer being Exec. VP and CFO
Nov 2, 2016Martin Clifford Tayler reported in an SEC filing no longer being Exec. VP of Global Operations
Nov 2, 2016Donna Felch reported in an SEC filing no longer being a director
Not reported recently (12)
  • Mario Eisenberger · Last reported as a director in an SEC filing dated Oct 2, 2024
  • Jesus Socorro · Last reported as a director in an SEC filing dated Nov 17, 2020
  • Charles T Todd Jr · Last reported as CEO of FHC Division in an SEC filing dated Jan 4, 2019
  • David R Bethune · Last reported as a director in an SEC filing dated Nov 1, 2018
  • O B Parrish · Last reported as a director in an SEC filing dated Jun 29, 2018
  • Mary Margaret Frank · Last reported as a director in an SEC filing dated May 4, 2018
  • Robert Getzenberg · Last reported as Chief Scientific Officer in an SEC filing dated May 4, 2018
  • Daniel Haines · Last reported as Chief Financial Officer in an SEC filing dated Dec 18, 2017
  • Brian J. Groch · Last reported as Chief Commercial Officer in an SEC filing dated Dec 18, 2017
  • Elgar Peerschke · Last reported as a director in an SEC filing dated Aug 4, 2017
  • Georges Makhoul · Last reported as a director in an SEC filing dated Aug 4, 2017
  • K&H Fisch Family Partners, LLC · Last reported as a 10% owner in an SEC filing dated Dec 6, 2016
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
3 ETFs hold VERU
3 shown · $1.94M total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $1.4M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $420,719 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $101,553 $1.2B 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.78
TTM Revenue
—
TTM Net Income
$-13.95M
TTM Op. Cash Flow
$-26.06M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-03-31—$-2.74M$-0.12$-8.91M
Q1 '262025-12-31—$-5.33M$-0.26$-6.17M
Q4 '252025-09-30—$1.45M$0.10$-5.49M
Q3 '252025-06-30—$-7.33M$-0.50$-5.48M
Q2 '252025-03-31—$-7.90M$-0.54$-7.74M
Q1 '252024-12-31—$-8.95M$-0.61$-11.33M
Q4 '242024-09-30$6.66M$-8.53M$-0.57$-4.37M
Q3 '242024-06-30—$-10.97M$-0.75$-5.65M
Q2 '242024-03-31—$-10.03M$-0.70$-5.65M
Q1 '242023-12-31—$-8.28M$-0.80$-6.02M
Q4 '232023-09-30$3.86M$-8.13M$-0.80$-9.49M
Q3 '232023-06-30$3.34M$-12.52M$-1.40$-18.43M
Q2 2026 • period ending 2026-03-31 • filed 2026-05-13
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.15
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-40.1%
ROA
-32.4%
Div Yield
0.00%
FCF Yield
-64.91%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$40.15M
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.40M
SI % of Float
9.67%
Days to Cover
12.71
Short Vol Ratio
60.3%
Free Float
14.50M
Float %
85.1%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-13